Showing results (301-310 of 315) with videos related to
Sort By:
Pageof 32
Communications Biology|May 13, 2025
Zebrafishology, study design guidelines for rigorous and reproducible data using zebrafishVictoria M Bedell, Priya Dubey, Han B Lee, et al.Cancer Research|February 9, 2024
Sarcoma Cells Secrete Hypoxia-Modified Collagen VI to Weaken the Lung Endothelial Barrier and Promote MetastasisYing Liu, Ileana Murazzi, Ashley M Fuller, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2017
Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor controlR J Klement, M Guckenberger, H Alheid, et al.BMC Cancer|March 15, 2018
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastasesN Andratschke, H Alheid, M Allgäuer, et al.Biological Reviews of the Cambridge Philosophical Society|September 12, 2008
A claim in search of evidence: reply to Manger's thermogenesis hypothesis of cetacean brain structureLori Marino, Camilla Butti, Richard C Connor, et al.Journal of the Neurological Sciences|September 29, 1999
Variation in in-patient stroke management in ten centres in different countries: the INCLEN multicentre stroke collaborationR Heller, R O'Connell, L Lim, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2022
Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trialA Dal Pra, P Ghadjar, S Hayoz, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2018
Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacyR J Klement, J Hoerner-Rieber, S Adebahr, et al.Leukemia|December 22, 2017
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over timeS K Kumar, A Dispenzieri, R Fraser, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2017
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung diseaseS Tanadini-Lang, J Rieber, A R Filippi, et al.Pageof 32